» Articles » PMID: 37325668

The Impact of Epigenetic Modifications on Allogeneic Hematopoietic Stem Cell Transplantation

Overview
Journal Front Immunol
Date 2023 Jun 16
PMID 37325668
Authors
Affiliations
Soon will be listed here.
Abstract

The field of epigenetics studies the complex processes that regulate gene expression without altering the DNA sequence itself. It is well established that epigenetic modifications are crucial to cellular homeostasis and differentiation and play a vital role in hematopoiesis and immunity. Epigenetic marks can be mitotically and/or meiotically heritable upon cell division, forming the basis of cellular memory, and have the potential to be reversed between cellular fate transitions. Hence, over the past decade, there has been increasing interest in the role that epigenetic modifications may have on the outcomes of allogeneic hematopoietic transplantation and growing enthusiasm in the therapeutic potential these pathways may hold. In this brief review, we provide a basic overview of the types of epigenetic modifications and their biological functions, summarizing the current literature with a focus on hematopoiesis and immunity specifically in the context of allogeneic hematopoietic stem cell transplantation.

Citing Articles

Modulation of biological activities in adipose derived stem cells by histone deacetylation.

Abdallah S, Tabebi M, Qanadilo S, Ali N, Wang J, Darcy P Sci Rep. 2025; 15(1):3629.

PMID: 39880862 PMC: 11779964. DOI: 10.1038/s41598-024-84652-1.


Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells.

Huang C, Qing L, Xiao Y, Tang J, Wu P Biomolecules. 2024; 14(1).

PMID: 38275745 PMC: 10813482. DOI: 10.3390/biom14010004.

References
1.
Challen G, Sun D, Jeong M, Luo M, Jelinek J, Berg J . Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet. 2011; 44(1):23-31. PMC: 3637952. DOI: 10.1038/ng.1009. View

2.
Jaiswal S, Ebert B . Clonal hematopoiesis in human aging and disease. Science. 2019; 366(6465). PMC: 8050831. DOI: 10.1126/science.aan4673. View

3.
Sun Y, Wang Y, Toubai T, Oravecz-Wilson K, Liu C, Mathewson N . BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 2015; 125(17):2724-8. PMC: 4408296. DOI: 10.1182/blood-2014-08-598037. View

4.
Wei Y, Xiong X, Li X, Lu W, He X, Jin X . Low-dose decitabine plus venetoclax is safe and effective as post-transplant maintenance therapy for high-risk acute myeloid leukemia and myelodysplastic syndrome. Cancer Sci. 2021; 112(9):3636-3644. PMC: 8409404. DOI: 10.1111/cas.15048. View

5.
Gamper C, Agoston A, Nelson W, Powell J . Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J Immunol. 2009; 183(4):2267-76. PMC: 2818975. DOI: 10.4049/jimmunol.0802960. View